Sterling Capital Management
BEAM icon

Sterling Capital Management’s Beam Therapeutics BEAM Stock Holding History

Sterling Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76.7K Buy
3,135
+2,616
+504% +$72.8K ﹤0.01% 1549
2026
Q2 		$17.8K Sell
519
-102
-16% -$3.08K ﹤0.01% 1942
2026
Q1 		$14.8K Buy
621
+6
+1% +$166 ﹤0.01% 2167
2025
Q4 		$17K Buy
615
+383
+165% +$9.8K ﹤0.01% 2317
2025
Q3 		$5.63K Buy
232
+1
+0.4% +$20 ﹤0.01% 2736
2025
Q2 		$3.93K Sell
231
-1,347
-85% -$23.5K ﹤0.01% 2640
2025
Q1 		$30.8K Sell
1,578
-831
-34% -$21.8K ﹤0.01% 1542
2024
Q4 		$59.7K Buy
2,409
+2,146
+816% +$54.8K ﹤0.01% 1566
2024
Q3 		$6.44K Buy
+263
New +$6.8K ﹤0.01% 1672

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Sterling Capital Management's BEAM Position: Q3 2026 in Review

Sterling Capital Management increased its Beam Therapeutics (BEAM) stake by 504% in Q3 2026, buying an estimated $72.8K and bringing the position to 3,135 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Sterling Capital Management first reported a position in BEAM in Q3 2024 and has held it in 9 quarters since. 191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Sterling Capital Management held 3,135 shares of Beam Therapeutics worth $76.7K as of Q3 2026.
  • Sterling Capital Management bought 2,616 Beam Therapeutics shares in Q3 2026, an estimated $72.8K.
  • Beam Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1549 holding.
  • Sterling Capital Management first reported a position in Beam Therapeutics in Q3 2024 and has held it in 9 quarters since.
  • 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.